<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35248526</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-7905</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>503</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of immunological methods</Title>
          <ISOAbbreviation>J Immunol Methods</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens.</ArticleTitle>
        <Pagination>
          <StartPage>113245</StartPage>
          <MedlinePgn>113245</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jim.2022.113245</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0022-1759(22)00032-1</ELocationID>
        <Abstract>
          <AbstractText>A multiplex assay for the quantitation of immunoglobulin G (IgG) serum antibodies directed against Clostridium tetani toxin (TT), Corynebacterium diphtheriae toxoid (DTxd), and the Bordetella pertussis antigens pertussis toxin (PT), filamentous hemagglutinin (FHA) and pertactin (Prn) was developed on an Evalution® platform to enhance the evaluation of the specific antibody response towards protein antigens in suspected humoral immunodeficiencies. Evalution® is a microfluidic and microparticle-based platform with the possibility to analyse single samples and to perform real-time kinetic measurements of antibody binding. All individual antigens were covalently linked to the carboxylated microparticles after which samples and fluorescently labelled detection antibodies were flowed over the microparticles in the microfluidic channels of the assay cartridges of the system. The developed assay showed very good sensitivity, specificity, and intra- and inter-assay coefficients of variation (CVs for the different antigens between 1.72-3.53% and 3.54-5.79%, respectively). Furthermore, the correlation of the Evalution pentaplex with a Luminex pentaplex using a panel of 48 human serum samples was excellent, with Spearman correlation coefficients between 0.936 for PT and 0.982 for DTxd (p &lt; 0.0001 for all). Finally, we showed in a proof-of-concept experiment the potential of the Evalution® platform to simultaneously measure concentrations and binding kinetics (as a surrogate for avidity) of the IgG antibodies to the selected protein antigens. Overall, these findings show that this new Evalution pentaplex can accurately measure the antibody response to TT, DTxd, PT, FHA and Prn. It also has the potential to measure antibody binding and dissociation kinetics.</AbstractText>
          <CopyrightInformation>Copyright © 2022. Published by Elsevier B.V.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>Debby</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>PharmAbs, KU Leuven, Leuven, Belgium; Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dillaerts</LastName>
            <ForeName>Doreen</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cockx</LastName>
            <ForeName>Maaike</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>PharmAbs, KU Leuven, Leuven, Belgium; Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ampofo</LastName>
            <ForeName>Louanne</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>PharmAbs, KU Leuven, Leuven, Belgium; Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>She</LastName>
            <ForeName>Joseph</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>MyCartis NV, Zwijnaarde, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Desombere</LastName>
            <ForeName>Isabelle</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Service Immune response, SD Infectious Diseases in Humans, Sciensano, Brussels, Belgium; National Reference Center for Bordetella pertussis, Sciensano, Brussels, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Geukens</LastName>
            <ForeName>Nick</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>PharmAbs, KU Leuven, Leuven, Belgium.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bossuyt</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>PharmAbs, KU Leuven, Leuven, Belgium; Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium; Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium. Electronic address: Xavier.bossuyt@uzleuven.be.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>04</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>J Immunol Methods</MedlineTA>
        <NlmUniqueID>1305440</NlmUniqueID>
        <ISSNLinking>0022-1759</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.4.2.31</RegistryNumber>
          <NameOfSubstance UI="D037342">Pertussis Toxin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001886" MajorTopicYN="N">Bordetella pertussis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004165" MajorTopicYN="Y">Diphtheria</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044085" MajorTopicYN="N">Microfluidics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037342" MajorTopicYN="N">Pertussis Toxin</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013742" MajorTopicYN="Y">Tetanus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="Y">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Diphtheria</Keyword>
        <Keyword MajorTopicYN="Y">Microfluidic Evalution platform</Keyword>
        <Keyword MajorTopicYN="Y">Multiplex</Keyword>
        <Keyword MajorTopicYN="Y">Pertussis</Keyword>
        <Keyword MajorTopicYN="Y">Specific antibody concentrations</Keyword>
        <Keyword MajorTopicYN="Y">Tetanus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35248526</ArticleId>
        <ArticleId IdType="doi">10.1016/j.jim.2022.113245</ArticleId>
        <ArticleId IdType="pii">S0022-1759(22)00032-1</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
